Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer|HER2-positive Biliary Tract Cancer|HER2-Positive Salivary Gland Carcinomas|HER2-Positive Advanced Solid Tumor
Interventions: DRUG: GQ1001
Sponsor: GeneQuantum Healthcare (Suzhou) Co., Ltd.